Muscular Dystrophies, Limb-Girdle
Neurology·MeSH: Muscular Dystrophies, Limb-Girdle
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| srp-9005 | Sarepta Therapeutics, Inc. (SRPT) |
Frequently asked questions
How many drugs are in development for Muscular Dystrophies, Limb-Girdle?
BioSniper tracks 1 drug in development for Muscular Dystrophies, Limb-Girdle across 1 company.
How many clinical trials target Muscular Dystrophies, Limb-Girdle?
There are 1 clinical trial targeting Muscular Dystrophies, Limb-Girdle tracked by BioSniper.
What is the prevalence of Muscular Dystrophies, Limb-Girdle?
The estimated prevalence of Muscular Dystrophies, Limb-Girdle is approximately 5.0 per 100,000 population.
Deep-dive into Muscular Dystrophies, Limb-Girdle
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis